Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-15

Clinical Trial Update: TELICAST : Telithromycin in Acute Exacerbations of Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial of telithromycin for acute exacerbations of asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED